Biocon shares gain over 2% on launch of cancer drug KRABEVA in India

Biocon share price gained 2.5 percent intraday Thursday after the biopharmaceuticals firm has launched KRABEVA, a biosimilar Bevacizumab, in India. The drug is used for the treatment of patients with metastatic

Loknath Das Loknath Das

Facebook Messenger Testing Snapchat-Like Streaks, Gets 4K Resolution Photo Support

HIGHLIGHTS For streaks, Messenger shows a lightning bolt icon and days counter Streaks provides a glance to 'fun facts' about the most active contacts 4K resolution support is rolling out

Loknath Das Loknath Das

Biocon climbs 2.65% on launch of cancer medicine

  Shares of Biocon jumped as much as 2.65 per cent in Tuesday as the company has launched its cancer biosimilar drug KRABEVA in India. Following a positive open at Rs 410

Loknath Das Loknath Das

PM Modi Launches Umang App to Provide Multiple Citizen-Centric Services Under One Roof

HIGHLIGHTS Umang app is available for both Android and iOS platforms The app gives access to tons of e-governance services There is Aadhaar-based authentication Prime Minister Narendra Modi on Thursday launched a

Loknath Das Loknath Das